This is a Validated Antibody Database (VAD) review about dogs FASN, based on 8 published articles (read how Labome selects the articles), using FASN antibody in all methods. It is aimed to help Labome visitors find the most suited FASN antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BD Biosciences
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD BioSciences, 610962) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4). Cells (2021) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD Biosciences, 610963) was used in western blot on human samples at 1:2000 (fig 3c). Cell Mol Gastroenterol Hepatol (2021) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD Transduction Laboratories, 610962) was used in western blot on rat samples (fig 5). Physiol Rep (2016) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD, 610962) was used in western blot on human samples (fig 2). Traffic (2016) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD Biosciences, 610963) was used in western blot on mouse samples at 1:2000 (fig 4). Nat Commun (2016) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD Transduction Laboratories, 610962) was used in immunohistochemistry on human samples at 1:500 (fig 6) and in western blot on human samples (fig 4D). Oncogenesis (2015) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (bD Bioscience, 610962) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Oncotarget (2015) ncbi |
mouse monoclonal (23/Fatty Acid Synthase) |
| BD Biosciences FASN antibody (BD Bioscience, 610962) was used in immunohistochemistry - paraffin section on mouse samples . Am J Physiol Endocrinol Metab (2014) ncbi |
Articles Reviewed
- Li X, Tao J, Cigliano A, Sini M, Calderaro J, Azoulay D, et al. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102-15 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments